What Researchers Did
Researchers describe how hyperbaric oxygen therapy (HBOT) was used to treat a 76-year-old woman who developed severe tissue damage near her urethra after radiation therapy for cervical cancer.
What They Found
The patient received two cycles of HBOT, involving daily 60-minute sessions of 100% oxygen at 2.4 atmospheres absolute, five days a week for six weeks per cycle. Following treatment, the damaged tissue was completely replaced by normal mucosa, and no adverse effects were observed during the therapy.
What This Means for Canadian Patients
For Canadian patients experiencing radiation-induced tissue damage, such as necrosis near the urethra, after treatment for gynecological cancers, HBOT may offer a non-invasive and effective treatment option. This case suggests that HBOT could help restore normal tissue and improve quality of life for those suffering from these challenging late side effects of radiation therapy.
Canadian Relevance
Although the study was conducted in Japan, it covers radiation-induced soft tissue necrosis, which is a Health Canada-recognized indication for hyperbaric oxygen therapy.
Study Limitations
As a single case report, the findings from this study cannot be broadly generalized to all patients with similar conditions.